ZINC− a free database of commercially available compounds for virtual screening JJ Irwin, BK Shoichet Journal of chemical information and modeling 45 (1), 177-182, 2005 | 4754 | 2005 |
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing DE Gordon, GM Jang, M Bouhaddou, J Xu, K Obernier, KM White, ... Nature 583 (7816), 459-468, 2020 | 4455 | 2020 |
Relating protein pharmacology by ligand chemistry MJ Keiser, BL Roth, BN Armbruster, P Ernsberger, JJ Irwin, BK Shoichet Nature biotechnology 25 (2), 197-206, 2007 | 2146 | 2007 |
Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking MM Mysinger, M Carchia, JJ Irwin, BK Shoichet Journal of medicinal chemistry 55 (14), 6582-6594, 2012 | 2067 | 2012 |
Predicting new molecular targets for known drugs MJ Keiser, V Setola, JJ Irwin, C Laggner, AI Abbas, SJ Hufeisen, ... Nature 462 (7270), 175-181, 2009 | 1870 | 2009 |
Virtual screening of chemical libraries BK Shoichet Nature 432 (7019), 862-865, 2004 | 1691 | 2004 |
Benchmarking sets for molecular docking N Huang, BK Shoichet, JJ Irwin Journal of medicinal chemistry 49 (23), 6789-6801, 2006 | 1559 | 2006 |
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening SL McGovern, E Caselli, N Grigorieff, BK Shoichet Journal of medicinal chemistry 45 (8), 1712-1722, 2002 | 1359 | 2002 |
Automated docking with grid‐based energy evaluation EC Meng, BK Shoichet, ID Kuntz Journal of computational chemistry 13 (4), 505-524, 1992 | 1356 | 1992 |
Structure-based discovery of opioid analgesics with reduced side effects A Manglik, H Lin, DK Aryal, JD McCorvy, D Dengler, G Corder, A Levit, ... Nature 537 (7619), 185-190, 2016 | 973 | 2016 |
Large-scale prediction and testing of drug activity on side-effect targets E Lounkine, MJ Keiser, S Whitebread, D Mikhailov, J Hamon, JL Jenkins, ... Nature 486 (7403), 361-367, 2012 | 908 | 2012 |
The global phosphorylation landscape of SARS-CoV-2 infection M Bouhaddou, D Memon, B Meyer, KM White, VV Rezelj, MC Marrero, ... Cell 182 (3), 685-712. e19, 2020 | 885 | 2020 |
Prediction of protein− ligand interactions. Docking and scoring: successes and gaps AR Leach, BK Shoichet, CE Peishoff Journal of medicinal chemistry 49 (20), 5851-5855, 2006 | 880 | 2006 |
A relationship between protein stability and protein function. BK Shoichet, WA Baase, R Kuroki, BW Matthews Proceedings of the National Academy of Sciences 92 (2), 452-456, 1995 | 865 | 1995 |
The promise and peril of chemical probes CH Arrowsmith, JE Audia, C Austin, J Baell, J Bennett, J Blagg, C Bountra, ... Nature chemical biology 11 (8), 536-541, 2015 | 838 | 2015 |
Ultra-large library docking for discovering new chemotypes J Lyu, S Wang, TE Balius, I Singh, A Levit, YS Moroz, MJ O’Meara, T Che, ... Nature 566 (7743), 224-229, 2019 | 774 | 2019 |
A specific mechanism of nonspecific inhibition SL McGovern, BT Helfand, B Feng, BK Shoichet Journal of medicinal chemistry 46 (20), 4265-4272, 2003 | 737 | 2003 |
Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B TN Doman, SL McGovern, BJ Witherbee, TP Kasten, R Kurumbail, ... Journal of medicinal chemistry 45 (11), 2213-2221, 2002 | 706 | 2002 |
Lead discovery using molecular docking BK Shoichet, SL McGovern, B Wei, JJ Irwin Current opinion in chemical biology 6 (4), 439-446, 2002 | 680 | 2002 |
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms DE Gordon, J Hiatt, M Bouhaddou, VV Rezelj, S Ulferts, H Braberg, ... Science 370 (6521), eabe9403, 2020 | 631 | 2020 |